DK3502125T3 - Peptider og fremgangsmåder til detektering af LYME-sygdomsantifstoffer - Google Patents

Peptider og fremgangsmåder til detektering af LYME-sygdomsantifstoffer Download PDF

Info

Publication number
DK3502125T3
DK3502125T3 DK19150770.6T DK19150770T DK3502125T3 DK 3502125 T3 DK3502125 T3 DK 3502125T3 DK 19150770 T DK19150770 T DK 19150770T DK 3502125 T3 DK3502125 T3 DK 3502125T3
Authority
DK
Denmark
Prior art keywords
peptides
methods
lyme disease
disease antibodies
detecting lyme
Prior art date
Application number
DK19150770.6T
Other languages
English (en)
Other versions
DK3502125T5 (da
Inventor
Jeremy Walker
Cristina Cuesico
Rajesh K Mehra
Kenneth P Aron
Dennis M Bleile
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Application granted granted Critical
Publication of DK3502125T3 publication Critical patent/DK3502125T3/da
Publication of DK3502125T5 publication Critical patent/DK3502125T5/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326Magnetic particles
    • G01N33/54333Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • G01N33/54387Immunochromatographic test strips
    • G01N33/54388Immunochromatographic test strips based on lateral flow
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
DK19150770.6T 2011-11-04 2012-11-05 Peptider og fremgangsmåder til detektering af LYME-sygdomsantifstoffer DK3502125T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161556061P 2011-11-04 2011-11-04
EP12846033.4A EP2773654A4 (en) 2011-11-04 2012-11-05 PEPTIDES AND METHODS FOR DETECTION OF ANTIBODIES OF LYME DISEASE

Publications (2)

Publication Number Publication Date
DK3502125T3 true DK3502125T3 (da) 2023-12-04
DK3502125T5 DK3502125T5 (da) 2024-09-02

Family

ID=48192911

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19150770.6T DK3502125T5 (da) 2011-11-04 2012-11-05 Peptider og fremgangsmåder til detektering af LYME-sygdomsantifstoffer

Country Status (11)

Country Link
US (7) US8758772B2 (da)
EP (3) EP2773654A4 (da)
JP (3) JP6839485B2 (da)
KR (3) KR20140091735A (da)
CN (1) CN103998459A (da)
CA (1) CA2851540C (da)
DK (1) DK3502125T5 (da)
ES (1) ES2967710T3 (da)
FI (1) FI3502125T3 (da)
PL (1) PL3502125T3 (da)
WO (1) WO2013067524A1 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013009739A2 (en) * 2011-07-11 2013-01-17 Uvic Industry Partnerships Inc. Soluble treponema pallidum protein tp0453,tp0453-tp0326 fusion protein, and use in syphilis diagnosis
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
DK3489685T3 (da) * 2011-11-21 2023-12-04 Zoetis Services Llc Signalforstærkning i sidestrømning og tilsvarende immunoassays
US10294531B2 (en) 2013-10-07 2019-05-21 University Of Central Florida Research Foundation, Inc. Method, kits and materials for detection of Lyme disease Borrelia sp. infection
US9194870B2 (en) 2014-01-21 2015-11-24 Abaxis, Inc. Peptides, devices, and methods for the detection of Anaplasma antibodies
WO2015148721A1 (en) 2014-03-26 2015-10-01 Li-Cor, Inc. Laser desorption ionization mass spectrometry using a particulate separation bed
WO2016007549A1 (en) * 2014-07-07 2016-01-14 Veramarx, Inc. Biomarker signatures for lyme disease and methods of use thereof
TWI691716B (zh) 2014-08-13 2020-04-21 美商艾巴希斯公司 電漿特異性結合搭配物檢定中之信號放大
WO2016049148A1 (en) 2014-09-24 2016-03-31 Wellstat Diagnostics, Llc Compositions and methods for te diagnosis of lyme disease
DK3331818T3 (da) 2015-08-04 2024-08-12 Zoetis Services Llc Signalforstærkning i opløsningsbaserede plasmoniske assays med specifkke bindingspartnere
WO2017035389A1 (en) * 2015-08-27 2017-03-02 Quidel Corporation Immunoassay test device with two fluid flow paths for detection and differentiation of two or more analytes
CA2999078A1 (en) * 2015-09-25 2017-03-30 Qiagen Sciences Llc Compositions and methods for diagnosing lyme disease and for predicting lyme disease spirochete elimination after treatment
EP3359558B1 (en) 2015-10-06 2023-12-13 Bio-Rad Laboratories, Inc. Borrelia immunoassays and materials therefor
US10725038B2 (en) 2016-01-06 2020-07-28 Veramarx, Inc. Biomarker signatures for lyme disease differentiation and methods of use thereof
EP3252470B1 (en) * 2016-06-03 2020-07-29 Te?ted Oy A method and a solid support for detecting tick-borne microbes in a biological sample
US20170370925A1 (en) * 2016-06-27 2017-12-28 Tgr Biosciences Pty Ltd. Lateral Flow Analyte Detection
CN106397589A (zh) * 2016-10-31 2017-02-15 杭州贝英福生物科技有限公司 一种狭义伯氏疏螺旋体多克隆抗体及应用
CN106432487A (zh) * 2016-10-31 2017-02-22 杭州贝英福生物科技有限公司 一种伽氏疏螺旋体多克隆抗体及应用
JP7308148B2 (ja) 2017-01-30 2023-07-13 ゾエティス サービシズ リミテッド ライアビリティ カンパニー 溶液ベースのプラズモン特異的結合パートナーアッセイおよび金属ナノ構造体
CN106932567B (zh) * 2017-02-27 2018-10-30 天津市泌尿外科研究所 一种重组蛋白a介导的免疫靶向纳米金的制备方法
US11331019B2 (en) 2017-08-07 2022-05-17 The Research Foundation For The State University Of New York Nanoparticle sensor having a nanofibrous membrane scaffold
EP3688010A4 (en) * 2017-09-25 2021-08-18 The Trustees of Columbia University in the City of New York SEROLOGICAL TEST TO DETECT EXPOSURE TO AND INFECTION TO TICK-TRANSMITTED AGENTS
CN109596824A (zh) * 2019-01-04 2019-04-09 杭州奥泰生物技术股份有限公司 一种快速诊断莱姆病的检测试纸及其制备方法
US10928394B2 (en) 2019-02-07 2021-02-23 Julian R. K. Kage Rapid test for lyme bacteria
CN111018998B (zh) * 2019-12-04 2021-10-29 杭州傲锐生物医药科技有限公司 一种莱姆重组融合蛋白OspC-VlsE及其应用
EP4220166A1 (en) * 2022-02-01 2023-08-02 Universitat Rovira I Virgili (URV) In vitro method for detecting antibodies in a sample

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366246A (en) 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
US4888276A (en) 1986-06-26 1989-12-19 Minnesota Mining And Manufacturing Company Method and composition for the diagnosis of Lyme disease
US4721617A (en) 1986-08-14 1988-01-26 Regents Of The University Of Minnesota Vaccine against lyme disease
US5385826A (en) 1989-04-21 1995-01-31 Gundersen Medical Foundation, Ltd. Diagnostic assay for lyme disease
DE4015911A1 (de) 1989-09-19 1991-03-28 Max Planck Gesellschaft Impfstoff gegen die lyme-krankheit
US5187065A (en) 1989-12-22 1993-02-16 Schutzer Steven E Method and materials for detecting lyme disease
JPH06501382A (ja) 1990-06-15 1994-02-17 エール ユニバーシティ ライム病の予防および診断に用いる組成物および方法
US5155022A (en) 1991-02-08 1992-10-13 Becton, Dickinson And Company Assay for lyme disease
US5324630A (en) 1991-06-28 1994-06-28 The Regents Of The University Of California Methods and compositions for diagnosing lyme disease
US6221363B1 (en) 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
WO1993003184A1 (en) 1991-08-09 1993-02-18 Mccann Associates, Inc. Method for detecting lyme disease and composition
US5965702A (en) 1991-10-21 1999-10-12 Abbott Laboratories Borrelia burgdorferi antigens and uses thereof
US5618533A (en) 1992-02-11 1997-04-08 Yale University Flagellin-based polypeptides for the diagnosis of lyme disease
US5308753A (en) 1992-02-20 1994-05-03 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods for purifying and detecting IGM antibodies
US5620862A (en) 1993-11-24 1997-04-15 University Of Connecticut Methods for diagnosing early Lyme disease
US5618333A (en) 1995-03-28 1997-04-08 Buchholz, Jr.; Leroy H. Method for volatile organic compound recycling
US5932220A (en) 1995-05-08 1999-08-03 Board Of Regents University Of Texas System Diagnostic tests for a new spirochete, Borrelia lonestari sp. nov.
DE69733944T3 (de) 1996-02-21 2012-07-26 The Board Of Regents, The University Of Texas System Vmp-ähnliche sequenzen von pathogener borrelia
US6716574B2 (en) 1996-05-02 2004-04-06 Dako A/S Osp-C derived peptide fragments
US6902893B1 (en) 1997-06-20 2005-06-07 Gil H. Choi Lyme disease vaccines
CA2294701C (en) 1997-06-30 2009-09-08 The Administrators Of The Tulane Educational Fund Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
EP1173577A2 (en) 1999-04-21 2002-01-23 Boston Medical Center Corporation Prevention, diagnosis and treatment of lyme disease
US6475492B1 (en) 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease
US6665652B1 (en) 1999-07-28 2003-12-16 Richard B. Porwancher Method of diagnosis of lyme disease
US20030129680A1 (en) 2001-10-31 2003-07-10 O'connor Thomas Patrick Multi-analyte assay device
EP1390729A4 (en) 2001-05-03 2007-07-04 Immunetics Inc SYSTEMS AND METHODS FOR DETECTION OF ANALYTES IN BIOLOGICAL LIQUIDS
US6838247B2 (en) 2002-06-19 2005-01-04 Bowen Research And Training Test for lyme disease
EP2292762A3 (en) 2002-12-20 2012-12-12 Board of Regents, The University of Texas System VMP-like sequences of pathogenic Borrelia species and strains
US20060046310A1 (en) 2004-08-25 2006-03-02 Zong-Li Xia Amplification method for solid phase immunoassays
US7390626B2 (en) 2005-02-25 2008-06-24 Immunosciences Lab., Inc. Methods and kit for diagnosing tick borne illnesses
US8232045B2 (en) 2005-03-29 2012-07-31 Inverness Medical Switzerland Gmbh Colloidal metal conjugates
WO2007133623A2 (en) 2006-05-10 2007-11-22 Biopeptides Corporation Peptide diagnostic agent for lyme disease
US7776618B2 (en) 2007-03-01 2010-08-17 Church & Dwight Co., Inc. Diagnostic detection device
WO2009003177A1 (en) 2007-06-27 2008-12-31 Inbios International, Inc. Lateral flow assay system and methods for its use
EP2058663A1 (en) 2007-11-12 2009-05-13 Euro-Diagnostica B.V. Method for the immobilization of an analyte on a solid support
JP2009236685A (ja) 2008-03-27 2009-10-15 Sysmex Corp クロマトグラフィー用試験具
CN102791727A (zh) * 2009-11-17 2012-11-21 爱贝斯股份有限公司 用于检测莱姆病抗体的肽和方法
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies

Also Published As

Publication number Publication date
EP3502125A1 (en) 2019-06-26
EP4296673A3 (en) 2024-03-20
US20160109446A1 (en) 2016-04-21
US20130115634A1 (en) 2013-05-09
KR20230035134A (ko) 2023-03-10
KR102503883B1 (ko) 2023-02-27
CA2851540A1 (en) 2013-05-10
US11573227B2 (en) 2023-02-07
US20180372743A1 (en) 2018-12-27
EP2773654A4 (en) 2015-04-29
US20170356910A1 (en) 2017-12-14
US20140364332A1 (en) 2014-12-11
JP6839485B2 (ja) 2021-03-10
US20210140964A1 (en) 2021-05-13
US10073095B2 (en) 2018-09-11
PL3502125T3 (pl) 2024-03-11
KR20190137172A (ko) 2019-12-10
DK3502125T5 (da) 2024-09-02
EP2773654A1 (en) 2014-09-10
JP2019048811A (ja) 2019-03-28
CN103998459A (zh) 2014-08-20
EP4296673A2 (en) 2023-12-27
EP3502125B1 (en) 2023-11-01
US10921321B2 (en) 2021-02-16
KR20140091735A (ko) 2014-07-22
WO2013067524A1 (en) 2013-05-10
JP2015504420A (ja) 2015-02-12
US8758772B2 (en) 2014-06-24
ES2967710T3 (es) 2024-05-03
JP2021004251A (ja) 2021-01-14
FI3502125T3 (fi) 2023-12-21
US20230228747A1 (en) 2023-07-20
US9766238B2 (en) 2017-09-19
CA2851540C (en) 2022-05-03
US9201071B2 (en) 2015-12-01

Similar Documents

Publication Publication Date Title
DK3502125T5 (da) Peptider og fremgangsmåder til detektering af LYME-sygdomsantifstoffer
CY2023014I2 (el) Αντι il-36r αντισωματα
DK2785375T3 (da) Anti-pd-l1-antistoffer og anvendelser deraf
DK2812443T3 (da) Cd47-antistoffer og fremgangsmåder til anvendelse deraf
DK2766392T3 (da) Fremgangsmåde til oprensning af antistoffer
DK2768857T3 (da) Fremgangsmåder til oprensning af antistoffer
DK3556774T3 (da) Anti-CD40-antistoffer og anvendelser deraf
DK2710033T3 (da) Human immundefektvirus-neutraliserende antistoffer og fremgangsmåder til anvendelse deraf
DK2925782T3 (da) Anti-cd47-antistoffer og fremgangsmåder til anvendelse deraf
CO7020859A2 (es) Anticuerpos anti-cd134 (ox40) y usos de los mismos
DK2794905T3 (da) Modificerede polypeptider til bispecifikke antistofgrundstrukturer
CO7020862A2 (es) Proteinas de unión al antígeno cd27l
CO6811812A2 (es) Anticuerpo anti-b7-h3
DK3653645T3 (da) Monoklonal interleukin-31-antistof
DK3741883T5 (da) Antistofbiblioteker
DK2776833T3 (da) Cobinder-understøttet testfremgangsmåde
DK2659675T3 (da) Fremgangsmåde for billedsegmentering under anvendelse af søjler
BR112014011900A2 (pt) um método de purificação de anticorpo
DK2531526T3 (da) Fremgangsmåde til opnåelse af antistoffer
DK2673576T3 (da) Indretning til at adskille dråber og en anvendelse af en sådan indretning
DK2668210T3 (da) Anti-kit antistoffer og anvendelser deraf
CR20140127A (es) Anticuerpo anti-abtcr
DK2672979T3 (da) Anti-cd4-antistoffer til forebyggelse af især graft-versus-host-sygdom (gvhd)
ITRM20120383A1 (it) Metodo e kit per la rivelazione di anticorpi.
BR112013030352A2 (pt) proteínas de ligação do receptor fc